Kaufman, B., Trudeau, M., Awada, A., Blackwell, K., Bachelot, T., Salazar, V., et al. (2009) Lapatinib Momotherapy in Patients with HER2-Overexpressing Relapsed or Refractory Inflammatory Breast Cancer: Final Results and Survival of the Expanded HER2+ Cohort in EGF103009, a Phase II Study. The Lancet Oncology, 10, 581-588.

P63在HER2低表达乳腺癌中的表达及临床意义
Expression and Clinical Significance of P63 in HER2 Low-Expression Breast Cancer

冯 月, 张立雪, 欧江华   

临床医学进展Vol.13 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13122621, December 5 2023

复发/难治性弥漫大B细胞淋巴瘤CAR-T细胞治疗进展
Advances in CAR-T Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

乔万芬, 罗 伟   

临床医学进展Vol.13 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1351173, May 25 2023

血管紧张素II受体2型在乳腺癌患者中的表达及生物学意义
Expression and Biological Significanceof Angiotensin II Receptor Type 2 in Breast Cancer Patients

李 健, 王 颜    科研立项经费支持

临床医学进展Vol.11 No.10, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1110641, October 12 2021

外周血中性粒细胞与淋巴细胞比值在乳腺癌各分子分型预后中的意义
Significance of Peripheral Blood Neutrophil to Lymphocyte Ratio in the Prognosis of Breast Cancer

王真真, 杨雁鸿, 冯 博, 冯 悦, 李倩影, 王小玉   

亚洲肿瘤科病例研究Vol.5 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACRPO.2016.51002, July 29 2016

乳腺癌HER2指南更新要点对判读结果的影响及HER2阳性乳腺癌的特征
The Impact of the Update of Breast Cancer HER2 Guidelines on Interpretation Results and the Characteristics of HER2-Positive Breast Cancer

吴思雨, 魏志敏, 徐瑞祥, 曾满芹, 张龙宵, 董娴宁   

临床医学进展Vol.11 No.4, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.114223, April 15 2021

PIK3CA基因突变与HR阳性且HER2阴性乳腺癌的关系
The Relationship between PIK3CA Mutation and Hormone Receptor Positive and HER2 Negative Breast Cancer

依合里曼·买买提, 梁丽萍, 江志民, 马晓梅   

临床医学进展Vol.13 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.132384, February 23 2023